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Abstract Maintenance of adequate oxygenation is a
mainstay of intensive care, however, recommendations on
the safety, accuracy, and the potential clinical utility of
invasive and non-invasive tools to monitor brain and sys-
temic oxygenation in neurocritical care are lacking. A
literature search was conducted for English language arti-
cles describing bedside brain and systemic oxygen
monitoring in neurocritical care patients from 1980 to
August 2013. Imaging techniques e.g., PET are not con-
sidered. A total of 281 studies were included, the majority
described patients with traumatic brain injury (TBI). All
tools for oxygen monitoring are safe. Parenchymal brain
oxygen (PbtO2) monitoring is accurate to detect brain
hypoxia, and it is recommended to titrate individual targets
of cerebral perfusion pressure (CPP), ventilator parameters
(PaCO2, PaO2), and transfusion, and to manage intracranial
hypertension, in combination with ICP monitoring. SjvO2
is less accurate than PbtO2. Given limited data, NIRS is not
recommended at present for adult patients who require
neurocritical care. Systemic monitoring of oxygen (PaO2,
SaO2, SpO2) and CO2 (PaCO2, end-tidal CO2) is recom-
mended in patients who require neurocritical care.
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Introduction
Maintenance of adequate oxygenation is a primary objec-
tive of critical care, and the assessment of tissue
oxygenation is essential to patient management. Hypoxia is
defined as the reduction of tissue oxygenation to levels
insufficient to maintain cellular function and metabolism.
Hypoxia may result from ischemia—either macro-vascular
(reduced/absent cerebral blood flow [CBF] e.g., vascular
thrombosis, vasospasm, reduced carbon dioxide [PaCO2])
or micro-vascular (perivascular edema, blood–brain barrier
disruption, endothelial dysfunction)—anemia, and hypox-
emia. Cytopathic hypoxia is primarily from failure of the
cell to extract oxygen (e.g., oxygen diffusion barriers and/
or mitochondrial dysfunction).
Failure to maintain adequate oxygenation aggravates
secondary brain damage, therefore, detection and treatment
of brain and systemic hypoxia are important. Hyperoxia also
can aggravate outcome. Brain oxygen can be measured by
two invasive bedside techniques: brain tissue oxygen tension
(PbtO2) and jugular bulb oxygen saturation (SjvO2); or a
non-invasive bedside method: near-infrared spectroscopy
(NIRS). Monitoring of systemic oxygenation and CO2 can be
achieved invasively with arterial blood gas analysis and non-
invasively with pulse oximetry and end-tidal CO2 devices.
The Participants in the International Multidisciplinary Consensus
Conference on Multimodality Monitoring are listed in ‘‘Appendix’’
section
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The objective of this systematic review was to (1)
examine the safety and accuracy of systemic and brain
oxygen and CO2 monitoring; (2) evaluate its utility to
guide therapy; and (3) analyze whether oxygen or CO2
monitoring-guided therapy improves patient outcome after
acute brain injury (ABI) including traumatic brain injury
(TBI), subarachnoid hemorrhage (SAH), intracerebral
hemorrhage (ICH), acute ischemic stroke (AIS), or post-
cardiac arrest (CA) coma.
Methods
This systematic review was performed according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement [1].
Search Criteria
Studies were considered eligible based on the PICO
approach, which includes: (a) Patient population, i.e.,
critically ill TBI, SAH, ICH, AIS, or comatose CA
patients; (b) Intervention provided, i.e., PbtO2, SjvO2,
NIRS for regional cerebral oxygen saturation (rSO2),
arterial blood gas analysis (ABG) monitoring of arterial
oxygen saturation (SaO2)/partial arterial oxygen pressure
(PaO2)/partial arterial carbon dioxide pressure (PaCO2),
pulse oximetry (SpO2), capnometry for partial end-tidal
pressure of carbon dioxide (ETCO2); (c) Controls, i.e., ABI
patients without monitoring or patients without ABI who
underwent monitoring, or ABI patients monitored with
more than one device or in whom correlations with relevant
variables were analyzed; (d) Outcome endpoints, i.e.,
mortality, Glasgow Outcome Score (GOS), Glasgow Coma
Scale (GCS), modified Rankin Scale (mRS), functional
independence scores, neurological outcome, National
Institute of Health Stroke Scale, intensive care unit (ICU),
and hospital length of stay, duration of mechanical venti-
lation, complications, therapy modification, and changes in
physiological variables. Imaging techniques are not part of
this review. After selection, the evidence was classified and
practical recommendations were developed according to
the Grades of Recommendation, Assessment, Develop-
ment, and Evaluation (GRADE) system [2, 3].
Using the PubMed database, a systematic review was
performed (1980–August 2013) of the English language
literature. We did not consider unpublished data or congress
presentations/abstracts. The search strategy included the
terms: brain injury, traumatic brain injury (and related terms:
head trauma, neurotrauma, head injury), subarachnoid
hemorrhage, intracerebral hemorrhage, acute ischemic
stroke, large hemispheric infarction, malignant middle
cerebral artery infarction, cardiac arrest, hypoxic
encephalopathy, brain oxygen, brain tissue oxygen, brain
tissue oxygen pressure, brain tissue oxygen tension, brain
oxygenation, brain tissue oxygenation, near-infrared spec-
troscopy, cerebral oximetry, cerebral oxygenation, cerebral
tissue oxygenation, jugular bulb saturation, jugular venous
bulb oxygen saturation, jugular venous oxygen saturation,
jugular oximetry, systemic oxygenation, arterial oxygen
saturation, pulse oximetry, oximetry, central venous oxy-
genation, arterio-venous oxygen saturation difference,
partial arterial oxygen pressure, partial arterial carbon
dioxide pressure, blood gas analysis, ischemia, secondary
ischemia, brain hypoxia, brain tissue hypoxia, hypoxia,
cerebral ischemia, brain ischemia, delayed cerebral ische-
mia, vasospasm, cerebral perfusion imaging, mean arterial
pressure, intracranial pressure, cerebral perfusion pressure,
cerebral blood flow, hemoglobin, hematocrit, anemia,
transfusion, positive end expiratory pressure, fraction of
inspired oxygen, hypoxemia, mortality, Glasgow Outcome
Score, Glasgow Coma Scale, modified Rankin Scale, func-
tional independence scores, neurological outcome, National
Institute of Health Stroke Scale, Intensive Care Unit length
of stay, duration of ventilation, hospital length of stay, dis-
charge to home, discharge to institutional care, and
prognosis.
Study Selection and Data Collection
Articles were independently pre-selected according to their
title to identify those describing invasive brain oxygen,
non-invasive brain oxygen, and systemic oxygen monitor-
ing. We excluded: (a) review articles; (b) case reports or
case series with B5 patients; (c) animal studies; (d) pedi-
atric studies (<18 years); (e) studies that were not
conducted on ICU patients; and (f) studies performed on
patients without our pre-defined diseases.
Review Endpoints
The endpoints of this review were to answer the following
broad questions on oxygen monitoring: (1) is monitoring
safe and accurate, (2) does monitoring help guide man-
agement, and (3) does monitoring help to improve
outcome? Specific questions that were addressed include:
1. What are the indications for brain and systemic
oxygenation in neurocritical care patients?
2. What are the principal methods of reliable and
accurate brain oxygen monitoring?
3. What is the safety profile of brain oxygen monitoring?
4. What is the utility of brain oxygen monitoring to
determine prognosis in the comatose patient?
5. What is the utility of brain oxygen monitoring to direct
medical and surgical therapy?
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6. What is the utility of brain oxygen monitoring to
improve neurological outcome?
Grading of Evidence
The quality of available evidence was judged based on the
GRADE system. Summaries of the literature are followed
by recommendations. Additional findings and conclusions
are given in an on-line supplementary tables.
Results
Summary of the Literature
The initial search yielded 7,762 articles and abstracts and
529 articles were reviewed. After exclusions, the reviewers
identified 281 articles for inclusion; 161 for PbtO2, 57 on
SjvO2, 29 on NIRS, and 34 on systemic oxygenation
monitoring. More than two-thirds of the articles described
TBI patients. We found 3 randomized controlled trials
(RCT) for PbtO2 monitoring, 1 for SjvO2 monitoring, 1 for
NIRS monitoring, and 3 for systemic oxygen monitoring.
All other studies were non-RCT (case-controlled studies,
prospective/observational, retrospective studies). A large
majority were retrospective studies. The structure of this
chapter is separated into four main parts: (1) PbtO2, (2)
SjvO2, (3) NIRS, (4) ABG and ETCO2.
PbtO2 Monitoring
Regional brain tissue oxygen tension (PbtO2) monitoring
requires insertion of a catheter into the brain parenchyma
(sub-cortical white matter), through a single or multiple
lumen bolt or tunneled. Generally patients are selected for
PbtO2 monitoring when intracranial pressure (ICP) is
monitored.
Is PbtO2 Monitoring Safe and Accurate?
Eight studies tested safety and accuracy [4–11]: in sum-
mary, they found no catheter-related infections, 0–3 %
local bleeding around the catheter (with no clinical con-
sequence), 6–14 % technical complications (e.g.,
dislocation or defect). Catheters are MRI 1.5 Tesla com-
patible. For data accuracy, adaptation time was *2 h,
display error *2–3 mmHg, zero-drift *2 mmHg: display
errors and drift were greater during the first 4 days of
monitoring.
The Licox system from Integra Neurosciences and the
Neurovent-PTO system from Raumedic are currently
commercially available, and provide stable monitoring for
up to 7–10 days. In comparative studies, there are differ-
ences in absolute PbtO2 values, PbtO2 response to FiO2
increase, and PbtO2-derived indexes between the two devi-
ces [12–16]. Fever (*39 C) may affect the Licox data.
CBF and CPP are important determinants of PbtO2 [17–
30], but a PbtO2 monitor is not simply an ‘‘ischemia
monitor’’ since several variables such as PaCO2 [31–40],
PaO2 [23, 41, 42], systemic factors that modify CMRO2
(e.g., fever, shivering [43, 44]) alter PbtO2. PbtO2 best
reflects the product of CBF and arterio-venous oxygen
tension difference [23] and is influenced by the oxygen
diffusion gradient [45]. Hence, when local tissue extraction
of O2 is impaired (e.g., peri-vascular edema), PbtO2 may be
low despite normal CBF.
‘‘Normal’’ PbtO2 is 23-35 mmHg [5, 46, 47] but
depends on probe depth, being less in deeper brain regions
[5]. Values <20 mmHg are considered abnormal and have
been associated with greater evidence for cerebral ischemia
and energy dysfunction [48–50]. In many centers, treat-
ment is initiated when PbtO2 is <20 mmHg although other
authors describe treatment when PbtO2 is <15 mmHg
[51].
Probe location can influence how PbtO2 responds to
therapeutic interventions and its association with outcome
in TBI [52–56]. In general, PbtO2 absolute values and the
response of PbtO2 to FiO2 are less in peri-contusional areas
compared to normal brain visualized on CT scan [52–54,
56]. In SAH, the ability of a PbtO2 probe to detect ischemia
associated with vasospasm depends on probe placement
and is better when the MCA or ICA is involved [57]. It is
important, therefore, that PbtO2 data be interpreted once a
post-insertion CT scan has verified probe position.
Does PbtO2 Monitoring Help Guide Management?
Most studies include comatose TBI patients and less fre-
quently SAH patients. PbtO2 monitoring can guide several
aspects of patient care. PbtO2 monitoring helps target
‘‘optimal CPP levels’’ (i.e., a CPP level to prevent/treat
brain tissue hypoxia, [PbtO2 < 20 mmHg]) in individual
patients or a level at which ICP requires treatment in TBI
[22, 29, 58–62] and SAH [30, 63, 64]. PbtO2 data can be
used to identify deleterious effects of drugs on CPP [65–
67] and document the effect of interventions such as
induced hypertension to increase CPP [20, 68–70].
Patient’s autoregulation state can be identified using the
online correlation between CPP and PbtO2, or the oxygen
pressure reactivity index (ORx), which helps target CPP in
TBI [18, 21, 71–73], SAH [27, 74], and stroke [26]. The
effect of osmotherapy to control ICP can be guided by
PbtO2 data [75–78]. Other ICP therapies (hypothermia [79–
83], barbiturates [84, 85], or decompressive craniectomy
[86–88]) can be guided by PbtO2 data. In patients receiving
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hypothermia PbtO2 monitors may detect deleterious effects
associated with a change in CO2 affinity or with shivering
[43, 83, 89, 90]. Anemia (hemoglobin < 9 g/dl) is asso-
ciated with lower PbtO2 after TBI [91] and SAH [92, 93]
and PbtO2 monitoring may help guide transfusion end-
points [91, 94–97]. The variable effects of sedation,
anesthetic agents, and ‘‘wake-up tests’’ on individual
patients can be examined using PbtO2 data [98–105]. PbtO2
levels may help guide ventilator management [106]. There
is a well-described relationship between hyperventilation,
reduced PaCO2, and decreased PbtO2 as well as between
impaired lung function and low PbtO2: recruitment
maneuvers (PEEP of 30-40 cmH2O) may thus help
improve PbtO2 [107] but this effect may depend on
hemodynamic stability [108]. Finally PbtO2 monitor use
and changes in ORx are described in SAH induced vaso-
spasm management [27, 74, 109–117] both to provide
insight about an intervention or to ‘‘predict’’ delayed
cerebral ischemia [109, 110, 114].
Does PbtO2-Guided Care Influence Outcome?
Twenty-four studies (21 TBI, 3 SAH) describe an association
between reduced PbtO2 (using thresholds of <20, <15 and
<10 mmHg) and worse outcome. In TBI, reduced PbtO2 is
associated with mortality [118–123], lower GOS score [124–
130], and increased neuropsychological deficits [131]. PbtO2
values of 0 mmHg are consistent with brain death [132, 133].
The tissue oxygen response (TOR; i.e. PbtO2 response to
100 % FiO2) also is associated with TBI outcome [134–136].
In SAH there is a relationship between reduced PbtO2 and
mortality but the relationship with morbidity is less robust
than in TBI [114, 137, 138].
Interventions such as ventilator manipulation (e.g. a
change in FiO2 or PEEP), CPP augmentation, sedation, or
osmotherapy are most frequently used to treat low PbtO2.
Overall medical therapy can correct three quarters of the
episodes of compromised PbtO2 (<20 mmHg) but varies
with the specific therapy or combination of therapies [139,
140]. Increased FiO2 generally is the most effective therapy
and both normobaric and hyperbaric oxygen can increase
PbtO2, although the exact response may depend on probe
position [52, 141–149]. Whether this translates into
improved cerebral metabolism and better tissue outcome is
still controversial.
A physiologic response to therapy to correct PbtO2 is
associated with better outcomes in TBI and SAH [139,
150]. Nine observational studies have described the effect
of PbtO2-directed therapy used with ICP/CPP management
in severe TBI [151–159], suggesting a tendency to better
outcomes with combined PbtO2 and ICP/CPP therapy
compared to ICP/CPP therapy alone in the majority of
them.
SjvO2 Monitoring
Jugular bulb catheters sample the intracranial circulation.
Measuring jugular bulb venous oxygen saturation (SjvO2)
or the difference between arterial and jugular venous
oxygen content (AJVDO2) provides information about
global cerebral oxygenation. The catheter should be in the
dominant internal jugular vein and proximal to the first
extra-cranial tributary, the facial vein for best results [160–
163]. A cervical spine x-ray is recommended to define
correct position [164].
Is SjvO2 Monitoring Safe and Accurate?
Jugular bulb blood can be sampled intermittently with a
catheter or continuously using a fiberoptic catheter. Cath-
eters need frequent calibration usually every 8–12 h [165,
166]. Poor quality signals from extra-cranial contamination
associated with inaccurate placement, clot formation,
catheter, and venous thrombosis or inadequate calibration
are common [167–171]. Hence data accuracy ranges
between 40 and 80 % [171–173] of total monitored time.
Several studies have compared SvjO2 and PbtO2 monitor-
ing [172, 174–179]. Overall these studies show SjvO2 is
less accurate than PbtO2.
Normal SjvO2 is between 55 and 75 %. Although vari-
ous definitions have been used, SjvO2 values <55 % are
consistent with cerebral ischemia [180–185]. At least 13 %
of the brain volume needs to be ischemic for the SjvO2 to
be abnormal and so its ability to detect regional ischemia is
limited [186–191].
Can SjvO2 Monitoring Help Guide Management?
The majority of studies have been in TBI patients, with
only few data in SAH or AIS. Reduced CPP is a common
cause of SjvO2 desaturation [192–198] and optimization of
CPP can reduce these episodes of low SjvO2 [196, 197,
199, 200]. Increased ICP also is associated with reduced
SjvO2 [192, 201, 202] but the response of SjvO2 to ICP
treatment including hyperventilation, osmotherapy, sur-
gery, or hypothermia is variable [202–206]. A decrease in
SjvO2 associated with hyperventilation can be used to de-
escalate therapy i.e., guide hyperventilation during ICP
treatment [195, 196, 207–212]. A failure of AVDO2 to
improve once ICP is normalized is associated with a
greater likelihood of cerebral infarction [213]. Sedatives
such as propofol or opiates have an uncertain effect on
SjvO2 [103, 214, 215]. There are limited studies in SAH
but they suggest changes in SjvO2 or AVDO2 may precede
neurologic symptoms associated with vasospasm and so
can be used to titrate or institute induced hypervolemia or
hypertension [196, 216].
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Does SjvO2-Guided Care Influence Outcome?
In TBI patients, reduced SjvO2 [180–182, 184, 203, 217],
increased SjvO2 (>75 %) [180], and increased AVDO2
[185, 213, 218] are associated with worse outcome. An
SjvO2 < 50 % for more than 10 min or failure of the
AVDO2 to respond to treatment are associated with worse
outcome [182, 213].
In a randomized controlled study, Robertson et al. [200]
examined whether a CBF-targeted protocol, using higher
CPP and optimized volume management but without tar-
geting a specific range SjvO2 improved outcome compared
to standard ICP-based care in severe TBI. Patients assigned
to the CBF-targeted management had fewer episodes with
low SjvO2 < 55 % but 6-month outcome was similar
because of a greater incidence of pulmonary complications
in the CBF-targeted protocol group.
Near-Infrared Spectroscopy (NIRS)
Near-infrared spectroscopy (NIRS) is based on the prin-
ciple that light (wavelength 700–950 nm) passing
through biological tissue is absorbed by blood depending
on its oxygenation status. The attenuation of light allows
estimation of oxygen status in the tissue volume reached
by the light. While NIRS use is better described in
cardiothoracic surgery and in neonatal or pediatric criti-
cal care, we only reviewed studies in adult neurocritical
care in which commercially available devices were used.
Most of these studies are small, there are several meth-
odological limitations, and results are conflicting.
Furthermore, NIRS has several limitations in adult use
[219–223].
Currently, four commercial NIRS systems are available:
(1) FORE-SIGHT (CAS Medical Systems, Branford, Con-
necticut, USA; FDA-approved); (2) EQUANOX (Nonin
Medical, Plymouth, Minnesota, USA; FDA-approved); (3)
INVOS (Covidien, Boulder, Connecticut, USA; FDA-
approved); and (4) NIRO (Hamamatsu Photonics, Ham-
amatsu City, Japan; CE-marked). The INVOS and the NIRO
are the most widespread in clinical use. There is insufficient
data to recommend one device over the other. For inter-
monitor comparisons and technical aspects, the reader is
referred elsewhere [220, 223–237].
Is NIRS Monitoring Safe and Accurate?
While only two studies specifically addressed safety and the
application of NIRS [219, 238], no adverse effects were
described in other studies. Seventeen studies examined how
NIRS compared to other measures of brain oxygen and
perfusion including changes in these variables. The results
are very variable with good [222, 239–249], partial [219,
222, 238, 240–250], or poor correlation [251–254]. In large
part, this variability results from factors such as ambient
light, scalp, skull, and CSF conditions [223] or extra-cranial
circulation that influence the NIRS signal [220, 224].
Can NIRS Monitoring Help Guide Management?
Nineteen studies, mostly small observational studies,
describe how NIRS may be used to understand patient
physiology or guide management in neurocritical care. This
includes use in ICP waveform analysis [255]; cerebral
autoregulation [248, 249, 256]; CPP and MAP assessment
[60, 222, 251, 257–260]; vasospasm [221, 261, 262]; head
positioning [263], hematoma assessment, and surgical
decision making [264–266]. The results are mixed.
Does NIRS Monitoring Help to Improve Outcome?
There are very limited data on this question and no studies to
show that NIRS use helps to improve outcome in adult
neurocritical patients. Ideally, NIRS should be used with
other monitors and most studies suggest it is easy to incor-
porate NIRS into multimodal monitoring. This is best
exemplified in its use to assess cerebral autoregulation [248,
249].
NIRS: Conclusions
While NIRS is an attractive monitor since it is non-inva-
sive, it has several limitations in adult use and at present
has little if any role in adult neurocritical care. In partic-
ular, NIRS, alone, is currently not indicated for routine
monitoring of adult patients who require neurocritical care.
Instead if NIRS is to be used, it is best integrated with other
monitors to answer research questions but at the moment
not to guide management.
Systemic Oxygen Monitoring
Systemic oxygen can be measured invasively by arterial
blood gas analysis (ABG) for PaO2 and SaO2 and non-
invasively with pulse oximetry (for SpO2). There are a
variety of devices to assess systemic oxygenation but too
few technology validation studies in neurocritical care
patients to allow recommendation of one device over the
other. Most data are from TBI and SAH, thus limiting
generalizability. Most studies are small, non-controlled,
and suffer methodological weaknesses. Furthermore, sys-
temic oxygen monitoring usually is not the primary
endpoint but reported as part of the methods or as a sec-
ondary endpoint. Consequently, many studies were not
designed to answer the review questions directly and
instead provide indirect evidence only.
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Is Systemic Oxygen Monitoring Safe and Accurate?
No studies specifically address this question in neurocriti-
cal care patients, although these devices are used in
virtually all these patients. Pulse oximetry has been vali-
dated in healthy volunteers [267]. ABG and SpO2 use are
well studied in the operating room and the general ICU
where their use is safe and associated with fewer episodes
of hypoxia. The impact on outcome is less certain. There is
no plausible reason to assume that safety, applicability,
methodological reliability, or accuracy would be any dif-
ferent in neurocritical care patients although limited
precision has been identified in select circumstances [268–
270].
Can Systemic Oxygen Monitoring Help Guide
Management?
Systemic hypoxia and hyperoxia are known to exacerbate
outcome. Ten studies, including two small RCTs, addres-
sed how systemic oxygen monitoring can guide
neurocritical care management. In summary, pulse oxim-
etry or ABG analysis can reliably detect pulmonary and
circulatory abnormalities [271], and guide correction of
brain oxygen in select patients when using normobaric
hyperoxia [147, 272], PEEP [105, 107, 108, 273], recruit-
ment maneuvers [274, 275], or prone positioning [276].
Does Systemic Oxygen Monitoring Help to Improve
Outcome?
There are no outcome studies in neurocritical care that
compare patients managed with or without systemic oxy-
gen monitoring. However, two small observational studies
and one large retrospective registry provide indirect evi-
dence for the value of systemic oxygen monitoring in TBI.
In particular, desaturation on pulse oximetry or both low
and very high PaO2 are associated with worse outcome
[277–279]. Since cost and risk of systemic oxygen moni-
toring are low and the value in understanding patient
pathophysiology is high, there is no reason not to use
systemic oxygen monitoring as part of multimodal
monitoring.
Systemic Carbon Dioxide Monitoring
Systemic carbon dioxide is assessed invasively by arterial
blood gas analysis for PaCO2 and non-invasively with
capnography, capnometry, and continuous assessment of
end-tidal CO2 (ETCO2). There are several devices to assess
systemic carbon dioxide but too few technology validation
studies in neurocritical care to allow recommending one
device over the other. The reader is referred elsewhere for
details on technology [280–283].The vast majority of
studies on carbon dioxide monitoring are in TBI or SAH
and usually CO2 is not a primary endpoint, i.e., most evi-
dence is indirect.
Is Systemic Carbon Dioxide Monitoring Safe
and Accurate?
There is extensive research on CO2 analysis using ABG or
ETCO2 monitoring in general critical care and in anes-
thesia that demonstrate feasibility and safety. These
questions have not been specifically addressed in neuro-
critical care but there is no reason to expect a difference.
ABG-analysis of PaCO2 is routine and in widespread
use in all ICUs. Similarly, ETCO2 is used routinely in the
operating room [284]. End-tidal CO2 correlates with
PaCO2 in healthy ventilated patients but with impaired
pulmonary gas exchange (e.g., increased anatomic or
physiologic dead space, or low cardiac output) there can be
a gradient between ETCO2 and PaCO2 that may change
over time [257]. Hence ETCO2 is not a one-for-one sub-
stitute for PaCO2 and when ETCO2 is used it should be
validated against PaCO2.
Does Systemic Carbon Dioxide Monitoring Help Guide
Management?
Fifteen studies address this question; most are prospective
observational studies or case series and use ETCO2 or
PaCO2 monitoring [31, 186, 203, 285–292]. PaCO2 mon-
itoring and less reliably ETCO2 can help to detect and
guide hyperventilation. There is a reasonable relationship
with CBF and brain oxygen but less robust relationship
with CMRO2 and oligemia.
Does Systemic Carbon Dioxide Monitoring Help
to Improve Outcome?
There are no outcome studies in neurocritical care that
compare patients managed with or without systemic CO2
monitoring. Six studies, including one RCT provide indi-
rect evidence in that they show hyper- or, more often,
hypocapnia, to be associated with worse outcome or mor-
tality in TBI [279, 281, 293–295] and SAH [296]. Similar
to oxygen monitoring, it makes physiologic sense that CO2
monitoring be incorporated into multimodal monitoring.
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